Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 217,511 | 108,955 | -47,644 | 122,969 | 160,711 |
| Depreciation Amortization | 375,870 | 288,653 | 198,922 | 123,230 | 402,208 |
| Income taxes - deferred | -106,337 | -79,777 | -46,098 | -26,532 | -115,539 |
| Accounts receivable | -37,009 | -18,845 | -20,881 | -9,485 | -8,518 |
| Other Working Capital | -103,285 | -130,303 | -134,379 | -77,642 | 139,776 |
| Other Operating Activity | 494,518 | 430,780 | 389,705 | 23,713 | 310,865 |
| Operating Cash Flow | $841,268 | $599,463 | $339,625 | $156,253 | $889,503 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -124,096 | -97,898 | -43,865 | -31,779 | 89,754 |
| Net Acquisitions | -303,451 | -303,451 | -303,451 | N/A | N/A |
| Purchase Of Investment | -1,959,365 | -1,602,843 | -1,333,327 | -598,310 | -1,454,147 |
| Sale Of Investment | 1,787,139 | 1,468,097 | 1,023,057 | 357,877 | 1,782,134 |
| Investing Cash Flow | $-599,773 | $-536,095 | $-657,586 | $-272,212 | $417,741 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -11,860 | -11,145 | -5,303 | 7,664 | -9,639 |
| Debt Issued | N/A | 15,304 | 15,231 | 4,441 | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -746,416 |
| Common Stock Issued | 146,959 | 86,838 | 74,487 | 56,356 | 119,619 |
| Common Stock Repurchased | -320,268 | -320,268 | -366 | N/A | -322,590 |
| Other Financing Activity | 36,759 | 12,293 | 10,241 | 15,195 | 10,503 |
| Financing Cash Flow | $-148,410 | $-216,978 | $94,290 | $83,656 | $-948,523 |
| Exchange Rate Effect | 124 | 36 | 607 | N/A | N/A |
| Beginning Cash Position | 568,168 | 568,168 | 568,168 | 568,168 | 209,447 |
| End Cash Position | 661,377 | 414,594 | 345,104 | 535,865 | 568,168 |
| Net Cash Flow | $93,209 | $-153,574 | $-223,064 | $-32,303 | $358,721 |
| Free Cash Flow | |||||
| Operating Cash Flow | 841,268 | 599,463 | 339,625 | 156,253 | 889,503 |
| Capital Expenditure | -198,312 | -133,840 | -79,722 | -65,630 | -318,376 |
| Free Cash Flow | 642,956 | 465,623 | 259,903 | 90,623 | 571,127 |